Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2019 | 75 | 08 |
Tytuł artykułu

Thrombocyte indices and plateletcrit in dogs with primary immune-mediated hemolytic anemia

Warianty tytułu
Języki publikacji
Primary immune-mediated hemolytic anemia (IMHA) is one of the most common autoimmune disorders in dogs. Platelet indices in dogs with IMHA have not been commonly used in daily clinical practice. The purpose of this study was to evaluate trombocyte indices, including platelet count (PLT), mean platelet volume (MPW), platelet size deviation width (PDW), and plateletcrit (PCT) in dogs with primary IMHA and to compare them with the corresponding values in a control series of healthy dogs. This study was performed on 21 dogs diagnosed with primary IMHA and 11 healthy dogs. The inclusion criteria were the presence of a positive Coombs’ test, true agglutination, anemia with HCT <35 %, hyperbilirubinemia, bilirubinuria, hemoglobinemia, hemoglobinuria, and spherocytosis. MPV and PDW were significantly higher in the dogs with IMHA compared to the reference population. No significant differences were found in PLT and PCT between the groups. The use of MPV and PDW values in evaluating the bone marrow response would be helpful in dogs with primary IMHA.
Słowa kluczowe
Opis fizyczny
  • Department of Internal Medicine, Ankara University Faculty of Veterinary Medicine, Ankara, Turkey
  • Department of Internal Medicine, Ankara University Faculty of Veterinary Medicine, Ankara, Turkey
  • Balch A., Mackini A.: Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis, compendium on continuing education for the practising veterinarian. Compendium 2007, 29, 217-225.
  • Bommer N. X., Shaw D. J., Milne E. M., Ridyard A. E.: Platelet distribution width and mean platelet volume in the interpretation of thrombocytopenia in dogs. JSAP 2008, 49, 518-524.
  • Botsch V., Küchenhoff H., Hartmann K., Hirschberger J.: Retrospective study of 871 dogs with thrombocytopenia. Vet. Rec. 2009, 164, 647-651.
  • Carr A. P., Panciera D. L., Kidd L.: Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: A retrospective study of 72 cases. JVIM 2002, 16, 504-509.
  • Gerday E., Baer V. L., Lambert D. K., Paul D. A., Sola-Visner M. C., Pysher T. J., Christensei R. D.: Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit. Transfusion 2009, 49, 2034-2039.
  • Jain N. C. (ed.): Hemolytic anemia of noninfectious origin, [in:] Schalm’s Veterinary Hematology. Lea&Febiger, Philadelphia 1986, p. 647-651.
  • Kaito K., Otsubo H., Usui N., Yoshida M., Tanno J., Kurihara E., Matsumoto K., Hirata R., Domitsu K., Kobayashi M.: Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. BJH 2005, 128, 698-702.
  • Kamath S.: Platelet activation: assessment and quantification. Europ. Heart J. 2001, 22, 1561-1571.
  • Kelley J., Sharkey L. C., Christopherson P., Rendahl A.: Platelet count and plateletcrit in Cavalier King Charles Spaniels and Greyhounds using the advia 120/2120. Vet. Clin. Pathol. 2014, 43, 43-49.
  • Klag A., Giger U., Shofer F.: Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990). JAVMA 1993, 202, 783-788.
  • Kristensen A. T., Weiss D. J., Klausner J. S.: Platelet dysfunction associated with immune-mediated thrombocytopenia in dogs. JVIM 1994, 8, 323-327.
  • Loo B., Martin J. F.: Megakaryocytes and platelets in vascular disease. Baillieres Clin. Haematol. 1997, 10, 109-123.
  • McCullough S.: Immune-mediated hemolytic anemia: understanding the nemesis. Vet. Clin. North Am. Small Anim. Pract. 2003, 33, 1295-1315.
  • Northern J., Tvedten H. W.: Diagnosis of microthrombocytopenia and immunemediated thrombocytopenia in dogs with thrombocytopenia: 68 cases (1987-1989). JAVMA 1992, 200, 368-372.
  • O’Marra S. K., Delaforcase A. M., Shaw S. P.: Treatment and predictors of outcome in dogs with immune-mediated thrombocytopenia. JAVMA 2011, 238, 346-352.
  • Pedersen H. D., Haggström J., Olsen L. H., Christenseni K., Selin A., Burmeister M. L., Larsen H.: Idiopathic asymptomatic thrombocytopenia in Cavalier King Charles Spaniels is an autosomal recessive trait. JVIM 2002, 16, 169-173.
  • Putsche J. C., Kohn B.: Primary immune-mediated thrombocytopenia in 30 dogs (1997-2003). JAAHA 2008, 44, 250-257.
  • Schwartz D., Sharkey L., Armstrong P. J., Knudson C., Kelley J.: Platelet Volume and Plateletcrit in Dogs with Presumed Primary Immune-Mediated Thrombocytopenia. JVIM 2014, 28, 1575-1579.
  • Scott-Moncrieff J. C., Treadwell N. G., McCullough S. M., Brooks M. B.: Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. JAAHA 2001, 37, 220-227.
  • Smith J. R., Smith K. F., Brainard B. M.: Platelet parameters from an automated hematology analyzer in dogs with inflammatory clinical diseases. Vet. J. 2014, 201, 406-411.
  • Souza A. M., Pereira J. J., Campos S. D. E., Filho R. A., Xavier M. S., Bacellar D. T. L., Almosny N. R. P.: Platelet indices in dogs with thrombocytopenia and dogs with normal platelet counts. Arch. Med. Vet. 2016, 48, 277-281.
  • Sullivan P. S., Manning K. L., Mcdonald T. P.: Association of mean platelet volume and bone marrow megakaryopoiesis in thrombocytopenic dogs: 60 cases (1984-1993). JAAHA 1995, 206, 332-334.
  • Tvedten H., Lilliehöök I., Hillström A., Häggström J.: Plateletcrit is superior to platelet count for assessing platelet status in Cavalier King Charles Spaniels. Vet. Clin. Pathol. 2008, 37, 266-271.
  • Weiss D. J., Brazzell J. L.: Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia. JVIM 2006, 20, 682-686.
  • Žvorc Z., Bari Rafaj R., Kuleš J., Mrljak V.: Erythrocyte and platelet indices in babesiosis of dogs. Vet. Arhiv. 2010, 80, 259-267.
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.